Late Rally Snaps Market's Two-Day Skid
We saw another late move in the market on Thursday, but this time the action was to the upside and left all of the major indices higher for the session. The rally snapped a...
Symbol | Exchange | Currency |
|---|
We saw another late move in the market on Thursday, but this time the action was to the upside and left all of the major indices higher for the session. The rally snapped a...
SPECIAL ALERT: Remember, we need your input to make next week’s new Zacks Ultimate Strategy Session episode the best it can be. There are two ways you can participate:1)...
SPECIAL ALERT: The August episode of the Zacks Ultimate Strategy Session will be available for viewing no later than Wednesday, August 12. Kevin Matras, David Bartosiak, Tracey...
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. The Company is focused on discovering, developing and marketing of pharmaceuticals for the treatment of neurological, endocrine and psychiatric-based diseases and disorders. Its portfolio includes treatments for tardive dyskinesia, Parkinson’s disease, endometriosis and uterine fibroids. Its product pipeline includes INGREZZA (valbenazine), which provides a once-daily dosing treatment option for tardive dyskinesia and has three dosing options (40 milligram (mg), 60 mg and 80 mg capsules); ONGENTYS (opicapone) is an adjunctive therapy to levodopa/carbidopa in patients with Parkinson’s disease; ORILISSA (elagolix) is used for the management of moderate to severe endometriosis pain in women, and ORIAHNN (elagolix, estradiol, and norethindrone acetate and elagolix capsules) is a non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in women.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
| Technical Indicators | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Buy |
| Summary | Strong Buy | Strong Buy | Strong Buy | Strong Buy | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 49.22 | 49.30 | 47.30 | +1.02 | +2.12% | 1.97M | NYSE | |||
| 40.64 | 40.67 | 39.05 | +1.77 | +4.55% | 3.08M | NYSE | |||
| 1.17 | 1.99 | 1.16 | -0.740 | -38.74% | 65.94M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 22.05 | 22.90 | 21.77 | +0.03 | +0.14% | 33.68M | NYSE | |||
| 0.136 | 0.1366 | 0.1303 | -0.0010 | -0.73% | 1.81M | NYSE | |||
| 8.01 | 8.06 | 7.54 | +0.43 | +5.67% | 4.58M | NYSE | |||
| 1.09 | 1.10 | 1.00 | +0.0906 | +9.07% | 6.75M | NYSE | |||
| 87.08 | 87.53 | 83.08 | +4.65 | +5.64% | 86.69M | NASDAQ | |||
| 96.48 | 96.76 | 95.31 | +1.51 | +1.59% | 1.10M | NYSE | |||
| 17.01 | 17.07 | 16.68 | +0.49 | +2.97% | 3.40M | NYSE | |||
| 21.59 | 22.58 | 21.03 | +0.450 | +2.13% | 8.24M | NYSE | |||
| 30.05 | 30.95 | 29.94 | -0.36 | -1.18% | 14.78M | NYSE | |||
| 5.26 | 5.417 | 5.15 | +0.090 | +1.74% | 60.16K | NYSE | |||
| 113.77 | 113.96 | 109.43 | +4.27 | +3.90% | 1.80M | NYSE |